PD-1 Inhibitor for a Non-Small-Cell Lung Cancer Patient With Paraneoplastic Nephropathy

Arch Bronconeumol (Engl Ed). 2021 Apr;57(4):311-312. doi: 10.1016/j.arbres.2020.12.029. Epub 2021 Jan 27.

[Article in English, Spanish]

Authors

Hironori Yoshida¹, Shigeaki Iwatsubo², Takashi Nishimura²

Affiliations

¹ Department of Respiratory Medicine, Kyoto Katsura Hospital, Kyoto, Japan; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Electronic address: highd42@kuhp.kyoto-u.ac.jp.
² Department of Respiratory Medicine, Kyoto Katsura Hospital, Kyoto, Japan.

PMID: 33612332
DOI: 10.1016/j.arbres.2020.12.029

No abstract available

Publication types

Case Reports

MeSH terms

Autoantibodies / therapeutic use
Carcinoma, Non-Small-Cell Lung* / complications
Carcinoma, Small Cell* / drug therapy
Humans
Immune Checkpoint Inhibitors
Lung Neoplasms* / complications

Substances

Autoantibodies
Immune Checkpoint Inhibitors